Showing results (61-70 of 168) with videos related to

Sort By:
Pageof 17
Respirology (Carlton, Vic.)|June 3, 2008
Patient satisfaction with sedation for flexible bronchoscopyTakashi Hirose, Kentaro Okuda, Hiroo Ishida, et al.
Metabolism: Clinical and Experimental|August 31, 2004
Effects of atorvastatin on triglyceride-rich lipoproteins, low-density lipoprotein subclass, and C-reactive protein in hemodialysis patientsAyako Ikejiri, Tsutomu Hirano, Satoru Murayama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 19, 2008
[Two cases with recurrent non-small cell lung cancer successfully treated with cisplatin and S-1]Takashi Hirose, Takamichi Hosaka, Masanao Nakashima, et al.
International Archives of Allergy and Immunology|April 21, 2016
A Phase 2a Study of Benralizumab for Patients with Eosinophilic Asthma in South Korea and JapanHae-Sim Park, Mi-Kyeong Kim, Nobuyuki Imai, et al.
American Journal of Hypertension|January 31, 2007
Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertensionToshiaki Suguro, Takuya Watanabe, Yoshiyuki Ban, et al.
Biochemical and Biophysical Research Communications|May 7, 2003
Lipoprotein lipase mRNA in white adipose tissue but not in skeletal muscle is increased by pioglitazone through PPAR-gammaHaruaki Kageyama, Tsutomu Hirano, Kenta Okada, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2002
Phase I study of the combination of gemcitabine and nedaplatin for treatment of previously untreated advanced non-small cell lung cancerTakashi Hirose, Naoya Horichi, Tohru Ohmori, et al.
Circulation|March 5, 2003
Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressureTakuya Yokoe, Kenji Minoguchi, Hirofumi Matsuo, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|June 11, 2019
Asthma exacerbations in patients with asthma and rhinitis: Factors associated with asthma exacerbation and its effect on QOL in patients with asthma and rhinitisKen Ohta, Hiroshi Tanaka, Yuji Tohda, et al.
Plos One|April 21, 2015
Long-Term Once-Daily Tiotropium Respimat® Is Well Tolerated and Maintains Efficacy over 52 Weeks in Patients with Symptomatic Asthma in Japan: A Randomised, Placebo-Controlled StudyKen Ohta, Masakazu Ichinose, Yuji Tohda, et al.
Pageof 17